Back to Authors

Liu, Lingyun

https://orcid.org/0000-0002-7431-7399

A5102026436 | I95746587

Mayo Clinic

Cytel (United States)

Citations 2

Efficacy and Safety of TRC105 Plus Pazopanib vs Pazopanib Alone for Treatment of Patients With Advanced Angiosarcoma

JAMA Oncology | March 31, 2022 | Volume: 8 | Issue: 5 | Pages: 740

10.1001/jamaoncol.2021.3547 | PMID 35357396

TAPPAS: An adaptive enrichment phase 3 trial of TRC105 and pazopanib versus pazopanib alone in patients with advanced angiosarcoma.

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: TPS11590-TPS11590

10.1200/jco.2018.36.15_suppl.tps11590